Tranexamic acid formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8791160
APP PUB NO 20130018100A1
SERIAL NO

13620226

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMRING PHARMACEUTICALS INC1205 WESTLAKES DRIVE SUITE 275 BERWYN PA 19312

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Facemire, John W Douglasville, US 14 139
Greiwe, Jeffrey S Ft. Thomas, US 19 250
Heasley, Ralph A Webster Grove, US 41 555
Modest, Jason D Minneapolis, US 14 139
Moore, Keith A Loveland, US 31 350

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 29, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00